Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Autism Spectrum Disorders
|
331 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2016 | 2016 | ||||||
Carcinoma, Basal Cell
|
91 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2005 | 2005 | ||||||
Experimental Organism Basal Cell Carcinoma
|
63 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2005 | 2005 | ||||||
Lip and Oral Cavity Carcinoma
|
172 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2013 | 2013 | ||||||
Malignant neoplasm of mouth
|
184 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2013 | 2013 | ||||||
Glioma
|
353 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.040 | 0.500 | 4 | 2012 | 2017 | |||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 0.500 | 2 | 2013 | 2018 | |||||
Skin carcinoma
|
24 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 0.500 | 2 | 2007 | 2017 | |||||
Colorectal Carcinoma
|
1962 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 0.667 | 3 | 2007 | 2016 | |||||
Head and Neck Carcinoma
|
118 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 0.667 | 3 | 2010 | 2015 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 0.667 | 3 | 2010 | 2015 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 0.667 | 3 | 2007 | 2016 | |||||
Malignant neoplasm of skin
|
38 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 0.667 | 3 | 2005 | 2017 | |||||
Lymphoma, Non-Hodgkin
|
197 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.040 | 0.750 | 4 | 2009 | 2017 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.040 | 0.750 | 4 | 2003 | 2015 | |||||
Childhood Osteosarcoma
|
151 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.833 | 12 | 2012 | 2018 | |||||
Osteosarcoma
|
178 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.833 | 12 | 2012 | 2018 | |||||
Osteosarcoma of bone
|
151 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.833 | 12 | 2012 | 2018 | |||||
Malignant neoplasm of prostate
|
1082 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.070 | 0.857 | 7 | 2004 | 2018 | |||||
Prostate carcinoma
|
1168 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.070 | 0.857 | 7 | 2004 | 2018 | |||||
Stomach Carcinoma
|
652 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.080 | 0.875 | 8 | 2011 | 2016 | |||||
Breast Carcinoma
|
2793 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.090 | 0.889 | 9 | 2004 | 2018 | |||||
Malignant neoplasm of breast
|
3417 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.090 | 0.889 | 9 | 2004 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.090 | 0.889 | 9 | 2011 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.900 | 10 | 2002 | 2017 |